SCHEDULE: FMR LLC Discloses 6.4% Stake in Doximity Class A Stock

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a 6.4% beneficial ownership in Doximity Inc.'s Class A Common Stock as of September 30, 2025.

Summary

• FMR LLC and Abigail P. Johnson, as reporting persons, beneficially own an aggregate of 8,777,627.56 shares of Doximity Inc.'s Class A Common Stock.
• This ownership stake represents 6.4% of the total outstanding Class A Common Stock of Doximity Inc.
• The filing is an Amendment No. 4 to a Schedule 13G, indicating an update to a previously reported beneficial ownership position.
• FMR LLC holds sole voting power over 8,765,947.45 shares and sole dispositive power over 8,777,627.56 shares.
• Abigail P. Johnson holds sole dispositive power over 8,777,627.56 shares, with no sole or shared voting power directly attributed to her in this filing.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Doximity Inc.
• Several FMR LLC subsidiaries and affiliates, including Fidelity Management & Research Company LLC (which beneficially owns 5% or greater), are identified as entities that beneficially own shares.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would significantly alter the sentiment towards Doximity Inc. It confirms a continued significant institutional stake, which is generally neutral to slightly positive, but without context of previous filings, it's a routine update.

Positives

• A significant institutional investor, FMR LLC, maintains a substantial 6.4% stake in Doximity Inc., which can be interpreted as continued confidence in the company's prospects.
• The investment is stated to be in the ordinary course of business, suggesting a long-term investment strategy rather than an activist position aimed at control.

Negatives

• The filing itself does not contain any explicitly negative information regarding Doximity Inc. or the investment.

Risks

• The filing does not explicitly mention risks related to Doximity Inc.'s operations or financial health; it primarily focuses on the reporting person's ownership disclosure.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Doximity Inc.'s future performance or FMR LLC's investment strategy beyond the current ownership disclosure.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a routine disclosure of an institutional investor's stake and does not provide specific insights into broader industry trends or the competitive landscape for Doximity Inc. It confirms continued significant institutional ownership in the healthcare technology sector.

Stakeholder Impact

• Shareholders: Confirms a significant institutional investor's continued stake, which can be viewed positively as a vote of confidence.
• Management: Awareness of a large institutional holder's position.

Key Dates

Keywords

Doximity Inc, DXCM, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Class A Common Stock, Institutional Investor, Healthcare Technology